Inrig Jula bought TVTX

May 4, 2026 · Form 4 insider transaction

Inrig Jula bought 20,000 shares of Travere Therapeutics, Inc. at $22.40 per share, a transaction worth $448.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.